Understanding HIV, Cardiovascular Disease, and Inflammation

For individuals living with HIV, maintaining overall health extends beyond managing the virus itself. A growing body of research highlights a significant link between HIV, its treatment, and an increased risk of cardiovascular disease (CVD). This connection is largely driven by persistent inflammation, even in those undergoing antiretroviral therapy (ART). This article explores the complex relationship between HIV, ART, inflammation, and cardiovascular health, providing a comprehensive overview of the current understanding and implications for patient care.

The Link Between HIV and Cardiovascular Disease

Historically, CVD was less prevalent in people living with HIV compared to the general population. However, with the advent of ART, which has dramatically extended life expectancy for those with HIV, the incidence of atherosclerotic cardiovascular disease (ASCVD) – a condition characterized by plaque buildup in the arteries – has risen.¹ This suggests that long-term HIV infection and its treatment contribute to the development of CVD.

The Role of Inflammation

Persistent immune activation and chronic inflammation are hallmarks of HIV infection, even when viral load is suppressed by ART. This ongoing inflammation is believed to be a key driver of CVD in people living with HIV. Inflammation contributes to several processes that promote atherosclerosis, including:

• Endothelial Dysfunction: Inflammation damages the inner lining of blood vessels, impairing their ability to regulate blood flow.
• Plaque Formation: Inflammatory cells accumulate in the artery walls, contributing to the formation and instability of atherosclerotic plaques.
• Thrombosis: Inflammation increases the risk of blood clot formation, which can lead to heart attack or stroke.

Antiretroviral Therapy and Cardiovascular Risk

While ART is essential for controlling HIV and improving overall health, some ART regimens have been associated with an increased risk of CVD. Certain antiretroviral drugs can have metabolic side effects, such as elevated cholesterol and triglycerides, which further contribute to cardiovascular risk. However, it’s key to note that the benefits of ART in preventing HIV-related complications far outweigh the potential cardiovascular risks.

Comprehensive Care and Management

Managing cardiovascular risk in people living with HIV requires a comprehensive approach that includes:

• Regular Monitoring: Routine screening for cardiovascular risk factors, such as blood pressure, cholesterol, and glucose levels.
• Lifestyle Modifications: Adopting a heart-healthy lifestyle, including a balanced diet, regular exercise, and smoking cessation.
• ART Optimization: Selecting ART regimens with favorable metabolic profiles, when possible.
• Management of Comorbidities: Addressing other cardiovascular risk factors, such as hypertension and diabetes.

Specialized Care and Resources

Several organizations and medical centers offer specialized care for individuals with HIV and related health concerns:

• AltaMed: Provides comprehensive HIV care, including testing, PrEP, and wellness services.¹
• Los Angeles Family AIDS Network (LAFAN): Offers support and resources for individuals living with or at risk of HIV.¹
• Children’s Hospital Los Angeles: Provides specialized care for children and young adults with HIV and related immunological conditions.¹
• UCI Health: Offers allergy and immunology services, including care for patients with immune deficiencies.²
• UCLA Health: Provides access to allergists and immunologists specializing in various conditions, including asthma and immune defects.³

Looking Ahead

Ongoing research continues to unravel the complex interplay between HIV, inflammation, and cardiovascular disease. Future studies will focus on identifying novel therapeutic targets to reduce inflammation and mitigate cardiovascular risk in people living with HIV. By prioritizing comprehensive care and addressing cardiovascular risk factors proactively, we can improve the long-term health and well-being of this population.